# Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs

> **NCT02985684** · NA · COMPLETED · sponsor: **W.L.Gore & Associates** · enrollment: 125 (actual)

## Conditions studied

- Atrial Septal Defect

## Interventions

- **DEVICE:** GORE® CARDIOFORM ASD Occluder

## Key facts

- **NCT ID:** NCT02985684
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-10
- **Primary completion:** 2018-07-30
- **Final completion:** 2022-09-29
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985684, "Safety and Efficacy Study of Transcatheter Closure of Ostium Secundum ASDs". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02985684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*